Key | % Net Assets |
---|---|
Roche | 8.8% |
Novartis | 7.5% |
Koninklijke KPN | 4.0% |
TNT | 3.6% |
Other | 76.1% |
Name | % Net Assets |
---|---|
Roche | 8.8% |
Novartis | 7.5% |
Koninklijke KPN | 4.0% |
TNT | 3.6% |
Zurich Financial Services | 3.2% |
Vivendi Universal | 3.2% |
Thales | 3.1% |
Carrefour | 3.0% |
Group 4 Securicor | 3.0% |
CRH | 2.9% |
No asset data available.
Date | 24-Apr-2024 |
---|---|
NAV | 293.51p |
Currency | GBP |
Change | -0.010p |
% | n/a |
YTD change | 11.93p |
YTD % | 4.24% |
Fund Inception | 18/01/1986 |
---|---|
Fund Manager | Jeffrey Taylor |
TER | 1.19 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | n/a |
Savings | £20 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.18% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research